4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-056093
Chief Scientific Officer sold 63,606 shares at an average $28.25 ($1,796,676)
- Chief Scientific Officer acquired 55,606 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Michaelson Jennifer · Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +50,000 | $4.30 | $215,000 | 187,582 | D |
| 2024-05-06 | Sale : show line 2 in the form 10b5-1 | −37,723 | $27.82 | $1,049,454 | 149,859 | D |
| 2024-05-06 | Sale : show line 3 in the form 10b5-1 | −20,277 | $28.54 | $578,706 | 129,582 | D |
| 2024-05-07 | Exercise or conversion : show line 4 in the form 10b5-1 | +5,606 | $4.30 | $24,106 | 135,188 | D |
| 2024-05-07 | Sale : show line 5 in the form 10b5-1 | −5,606 | $30.06 | $168,516 | 129,582 | D |
| Open-market sales · 63,606 sh · avg $28.25 · $1,796,676 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-06 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −50,000 | 138,593 | D |
| 2024-05-07 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −5,606 | 132,987 | D |
Loading xslF345X05/ownership.xml…